These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 31004798)
21. Reconstitution and Characterization of BCL-2 Family Proteins in Lipid Bilayer Nanodiscs. Yao Y; Marassi FM Methods Mol Biol; 2019; 1877():233-246. PubMed ID: 30536010 [TBL] [Abstract][Full Text] [Related]
22. Structural basis for the interaction between DJ-1 and Bcl-X Lee MK; Lee MS; Bae DW; Lee DH; Cha SS; Chi SW Biochem Biophys Res Commun; 2018 Jan; 495(1):1067-1073. PubMed ID: 29175327 [TBL] [Abstract][Full Text] [Related]
23. Structural transition in Bcl-xL and its potential association with mitochondrial calcium ion transport. Rajan S; Choi M; Nguyen QT; Ye H; Liu W; Toh HT; Kang C; Kamariah N; Li C; Huang H; White C; Baek K; Grüber G; Yoon HS Sci Rep; 2015 May; 5():10609. PubMed ID: 26023881 [TBL] [Abstract][Full Text] [Related]
24. Bcl-xL Is Spontaneously Inserted into Preassembled Nanodiscs and Stimulates Bax Insertion in a Cell-Free Protein Synthesis System. Rouchidane Eyitayo A; Boudier-Lemosquet A; Chaignepain S; Priault M; Manon S Biomolecules; 2023 May; 13(6):. PubMed ID: 37371456 [TBL] [Abstract][Full Text] [Related]
25. Heat-induced dimerization of BCL-xL through alpha-helix swapping. Denisov AY; Sprules T; Fraser J; Kozlov G; Gehring K Biochemistry; 2007 Jan; 46(3):734-40. PubMed ID: 17223694 [TBL] [Abstract][Full Text] [Related]
26. C-terminal tail insertion of Bcl-xL in membrane occurs via partial unfolding and refolding cycle associating microsolvation. Maity A; Sinha S; Ganguly D; Ghosh Dastidar S Phys Chem Chem Phys; 2016 Aug; 18(34):24095-105. PubMed ID: 27525987 [TBL] [Abstract][Full Text] [Related]
27. Conformational switching, refolding and membrane insertion of the diphtheria toxin translocation domain. Ladokhin AS; Kyrychenko A; Rodnin MV; Vasquez-Montes V Methods Enzymol; 2021; 649():341-370. PubMed ID: 33712192 [TBL] [Abstract][Full Text] [Related]
28. Enhanced Sampling of Intrinsic Structural Heterogeneity of the BH3-Only Protein Binding Interface of Bcl-xL. Liu X; Jia Z; Chen J J Phys Chem B; 2017 Oct; 121(39):9160-9168. PubMed ID: 28903561 [TBL] [Abstract][Full Text] [Related]
29. Ceramide channels: destabilization by Bcl-xL and role in apoptosis. Chang KT; Anishkin A; Patwardhan GA; Beverly LJ; Siskind LJ; Colombini M Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):2374-84. PubMed ID: 26215742 [TBL] [Abstract][Full Text] [Related]
30. Comparison of lipid-dependent bilayer insertion of pHLIP and its P20G variant. Vasquez-Montes V; Gerhart J; King KE; Thévenin D; Ladokhin AS Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):534-543. PubMed ID: 29138065 [TBL] [Abstract][Full Text] [Related]
31. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations. Lama D; Sankararamakrishnan R Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209 [TBL] [Abstract][Full Text] [Related]
32. Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy. Shin JS; Ha JH; Chi SW Biochem Biophys Res Commun; 2014 Jan; 443(3):882-7. PubMed ID: 24342622 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of Bcl-xL prevents pro-death actions of ΔN-Bcl-xL at the mitochondrial inner membrane during glutamate excitotoxicity. Park HA; Licznerski P; Mnatsakanyan N; Niu Y; Sacchetti S; Wu J; Polster BM; Alavian KN; Jonas EA Cell Death Differ; 2017 Nov; 24(11):1963-1974. PubMed ID: 28777375 [TBL] [Abstract][Full Text] [Related]
34. A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein. Feng Y; Zhang L; Hu T; Shen X; Ding J; Chen K; Jiang H; Liu D Arch Biochem Biophys; 2009 Apr; 484(1):46-54. PubMed ID: 19161970 [TBL] [Abstract][Full Text] [Related]
35. A brewing understanding of the regulation of Bax function by Bcl-xL and Bcl-2. Renault TT; Dejean LM; Manon S Mech Ageing Dev; 2017 Jan; 161(Pt B):201-210. PubMed ID: 27112371 [TBL] [Abstract][Full Text] [Related]
36. Molecular basis of Bcl-xL's target recognition versatility revealed by the structure of Bcl-xL in complex with the BH3 domain of Beclin-1. Feng W; Huang S; Wu H; Zhang M J Mol Biol; 2007 Sep; 372(1):223-35. PubMed ID: 17659302 [TBL] [Abstract][Full Text] [Related]
37. The Structural Biology of Bcl-x Lee EF; Fairlie WD Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067648 [TBL] [Abstract][Full Text] [Related]
38. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins. Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548 [TBL] [Abstract][Full Text] [Related]
39. Probing Gallate-Mediated Selectivity and High-Affinity Binding of Epigallocatechin Gallate: a Way-Forward in the Design of Selective Inhibitors for Anti-apoptotic Bcl-2 Proteins. Olotu FA; Agoni C; Adeniji E; Abdullahi M; Soliman ME Appl Biochem Biotechnol; 2019 Mar; 187(3):1061-1080. PubMed ID: 30155742 [TBL] [Abstract][Full Text] [Related]
40. Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft. Zhang YH; Bhunia A; Wan KF; Lee MC; Chan SL; Yu VC; Mok YK J Mol Biol; 2006 Dec; 364(3):536-49. PubMed ID: 17011577 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]